NKG2D

Project-related publications
P6, P1, P3, P4, P7
Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference
bioRxiv
2025
P1, P3, P6, P7, Z
The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis
P7
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer
P3, P6, P7, Z
Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
P3, P4, P6, P7, Z